CXCL12-3′ G801A polymorphism is not a risk factor for breast cancer

DNA and Cell Biology

Volumn 29, Issue 8, 2010, Pages 423-427

  Kruszyna, Łukasz ^a   Lianeri, Margarita ^a   Rubis, Błazej ^a   Knuła, Hanna ^a   Rybczyńska, Maria ^a   Grodecka Gazdecka, Sylwia ^a   Jagodziński, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; BREAST TUMOR; GENETICS; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; POLAND; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CHEMOKINE CXCL12; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 77955879082     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1030     Document Type: Article

References (45)

1. Akashi, T., Koizumi, K., Tsuneyama, K., Saiki, I., Takano, Y., and Fuse, H. (2008). Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Sci 99, 539-542.
2. Bleul, C.C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., and Springer, T.A. (1996). The lymphocyte chemoattractant SDF-1 is a ligand for LESTR=fusin and blocks HIV-1 entry. Nature 382, 829-833.
3. Broxmeyer, H.E. (2008). Chemokines in hematopoiesis. Curr Opin Hematol 15:49-58.
4. Chang, C.C., Chen, S.C., Hsieh, Y.H., Chen, Y.C., Chen, T.Y., Chu, Y.H., Ma, H.J., Chou, M.C., Tsai, H.T., and Yang, S.F. (2009a). Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin Chem Lab Med 47, 412-418.
5. Chang, S.C., Lin, P.C., Yang, S.H., Wang, H.S., Li, A.F., and Lin, J.K. (2009b). SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Ann Surg Oncol 16, 2323-3230.
6. Dapic, V., Carvalho, M.A., and Monteiro, A.N. (2005). Breast cancer susceptibility and the DNA damage response. Cancer Control 12, 127-136.
7. de Oliveira, K.B., Oda, J.M., Voltarelli, J.C., Nasser, T.F., Ono, M.A., Fujita, T.C., Matsuo, T., and Watanabe, M.A. (2009). CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma. J Clin Lab Anal 23, 387-393.
8. Frierson, H.F., Jr., Wolber, R.A., Berean, K.W., Franquemont, D.W., Gaffey, M.J., Boyd, J.C., and Wilbur, D.C. (1995). Interobserver reproducibility of the Nottinghamm modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103, 195-198.
9. Garcia-Moruja, C., Rueda, P., Torres, C., Alcam?́, J., Luque, F., and Caruz, A. (2009). Molecular phenotype of CXCL12beta 30UTR G801A polymorphism (rs1801157) associated to HIV-1 disease progression. Curr HIV Res 7, 384-389.
10. Hassan, S., Baccarelli, A., Salvucci, O., and Basik, M. (2008). Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res 14, 446-454.
11. Hirata, H., Hinoda, Y., Kikuno, N., Kawamoto, K., Dahiya, A.V., Suehiro, Y., Tanaka, Y., and Dahiya, R. (2007). CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res 13, 5056-5062.
12. Huang, C.S., Chern, H.D., Chang, K.J., Cheng, C.W., Hsu, S.M., and Shen, C.Y. (1999). Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59, 4870-4875.
13. Kajiyama, H., Shibata, K., Terauchi, M., Ino, K., Nawa, A., and Kikkawa, F. (2008). Involvement of SDF-1alpha=CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer 122, 91-99.
14. Kijima, T., Maulik, G., Ma, P.C., Tibaldi, E.V., Turner, R.E., Rollins, B., Sattler, M., Johnson, B.E., and Salgia, R. (2002). Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 62, 6304-6311.
15. Kim, J., Mori, T., Chen, S.L., Amersi, F.F., Martinez, S.R., Kuo, C., Turner, R.R., Ye, X., Bilchik, A.J., Morton, D.L., and Hoon, D.S. (2006). Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg 244, 113-120.
16. Kimura, R., Nishioka, T., and Ishida, T. (2003). The SDF1-G801A polymorphism is not associated with SDF1 gene expression in Epstein-Barr virus-transformed lymphoblastoid cells. Genes Immun 4, 356-361.
17. Kruszyna, L., Lianeri, M., Rydzanicz, M., Szyfter, K., and Jagodziń ski, P.P. (2009). SDF1-30A gene polymorphism is associated with laryngeal cancer. Pathol Oncol Res. 2009 Oct 16. [Epub ahead of print, DOI: 10.1007=s12253-009-9214-5].
18. Lee, H.J., Kim, S.W., Kim, H.Y., Li, S., Yun, H.J., Song, K.S., Kim, S., and Jo, D.Y. (2009). Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Int J Oncol 34, 473-480.
19. Luker, K.E., and Luker, G.D. (2006). Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238, 30-41.
20. Maley, S.N., Schwartz, S.M., Johnson, L.G., Malkki, M., Du, Q., Daling, J.R., Li, S.S., Zhao, L.P., Petersdorf, E.W., and Madeleine, M.M. (2009). Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study. Int J Immunogenet 36, 367-375.
21. Maréchal, R., Demetter, P., Nagy, N., Berton, A., Decaestecker, C., Polus, M., Closset, J., Devière, J., Salmon, I., and Van Laethem, J.L. (2009). High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br J Cancer 100, 1444-1451.
22. McGrath, K.E., Koniski, A.D., Maltby, K.M., McGann, J.K., and Palis, J. (1999). Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol 213, 442-456.
23. Moser, B., and Loetscher, P. (2001). Lymphocyte traffic control by chemokines. Nat Immunol 2, 123-128.
24. Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S.N., Barrera, J.L., Mohar, A., Verástegui, E., and Zlotnik, A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56.
25. Oliveira-Neto, H.H., Silva, E.T., Leles, C.R., Mendonça, E.F., Alencar Rde, C., Silva, T.A., and Batista, A.C. (2008). Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas. Tumour Biol 29, 262-271.
26. Onai, N., Zhang, Y., Yoneyama, H., Kitamura, T., Ishikawa, S., and Matsushima, K. (2008). Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrowhematopoietic progenitor cells expressing SDF-1-intrakine. Blood 96, 2074-2080.
27. Orimo, A., Gupta, P.B., Sgroi, D.C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V.J., Richardson, A.L., and Weinberg, R.A. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elavated SDF-1=CXCL12 secretion. Cell 121, 335-348.
28. Parsa, P., and Parsa, B. (2009). Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac J Cancer Prev 10, 545-550.
29. Pemberton, N.C., Paneesha, S., Hiller, L., Starczynski, J., Hooper, L., Pepper, C., Pratt, G., and Fegan, C. (2006). The SDF-1 G>A polymorphismat position 801 plays no role inmultiplemyeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemia. Leuk Lymphoma 47, 1239-1244.
30. Razmkhah, M., Doroudchi, M., Ghayumi, S.M., Erfani, N., and Ghaderi, A. (2005). Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer 49, 311-315.
31. Razmkhah, M., Talei, A.R., Doroudchi, M., Khalili-Azad, T., and Ghaderi, A. (2004). Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 225, 261-266.
32. Shirozu, M., Nakano, T., Inazawa, J., Tashiro, K., Tada, H., Shinohara, T., and Honjo, T. (1995). Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28, 495-500.
33. Sobin, L.H. (2001). TNM: principles, history and relation to other prognostic factors. Cancer 91, 1589-1593.
34. Sobin, L.H., and Wittekind, C. (1997). TNM: Classification of Malignant Tumors, fifth edition (Wiley-Liss, New York).
35. Thelen, M, and Thelen, S. (2008). CXCR7, CXCR4 and CXCL12: an eccentric trio? J Neuroimmunol 198, 9-13.
36. Vairaktaris, E., Vylliotis, A., Spyridonodou, S., Derka, S., Vassiliou, S., Nkenke, E., Yapijakis, C., Serefoglou, Z., Neukam, F.W., and Patsouris, E. (2008). A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer. Anticancer Res 28, 271-275.
37. Vargo-Gogola, T., and Rosen, J.M. (2007). Modelling breast cancer: one size does not fit all. Nat Rev Cancer 7, 659-672.
38. Vázquez-Lavista, L.G., Lima, G., Gabilondo, F., and Llorente, L. (2009). Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Urology 74, 414-418.
39. Veronesi, U., Boyle, P., Goldhirsch, A., Orecchia, R., and Viale, G. (2005). Breast cancer. Lancet 365, 1727-1741.
40. Watanabe, M.A., de Oliveira Cavassin, G.G., Orellana, M.D., Milanezi, C.M., Voltarelli, J.C., Kashima, S., and Covas, D.T. (2003). SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals. Microb Pathog 35, 31-34.
41. Winkler, C., Modi, W., Smith, M.W., Nelson, G.W., Wu, X., Carrington, M., Dean, M., Honjo, T., Tashiro, K., Yabe, D., Buchbinder, S., Vittinghoff, E., Goedert, J.J., O'Brien, T.R., Jacobson, L.P., Detels, R., Donfield, S., Willoughby, A., Gomperts, E., Vlahov, D., Phair, J., and O'Brien, S.J. (1998). Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279, 389-393.
42. Yasuoka, H., Tsujimoto, M., Yoshidome, K., Nakahara, M., Kodama, R, Sanke, T., and Nakamura, Y. (2008). Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis. BMC Cancer 8, 340-350.
43. Zafiropoulos, A., Crikas, N., Passam, A.M., and Spandidos, DA. (2004). Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 41, e59.
44. Zlotnik, A. (2006). Chemokines and cancer. Int J Cancer 119, 2026-2029.
45. Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I., and Littman, D.R. (1998). Function of the chemokine receptor CXCR4 in hematopoiesis and in cerebellar development. Nature 393, 595-599.